Similar companies
Month over Month
Est. daily mentions of Cashtag on X.
| Dec 2025 | 4 | |
| Nov 2025 | 9 | |
| Oct 2025 | 15 | |
| Sep 2025 | 11 |
Analyzing X Mentions, how is Lineage Cell Therapeutics performing compared to its industry peers?
Lineage Cell Therapeutics underperforms its industry peers when it comes to X Mentions, ranking in the 1st percentile.
Why should an investor track X mentions?
Investors should track mentions of Lineage Cell Therapeutics on X because sudden increases in activity often reflect shifts in retail interest, sentiment, or breaking news. These signals can precede sharp price movements, offering valuable context for timing trades or identifying emerging opportunities.
Sign up and get more insights on Lineage Cell Therapeutics.
Sentiment on X
The sentiment score for Lineage Cell Therapeutics on X is 69 (out of 100). This is considered neutral. Sentiment today is down compared to the 30 moving average.
